GPATCH4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.957000E-01
Normal-vs-Stage2
6.980800E-01
Normal-vs-Stage3
7.329800E-01
Normal-vs-Stage4
2.163800E-02
Stage1-vs-Stage2
8.629600E-01
Stage1-vs-Stage3
3.864800E-01
Stage1-vs-Stage4
7.074200E-02
Stage2-vs-Stage3
3.608400E-01
Stage2-vs-Stage4
4.220200E-02
Stage3-vs-Stage4
3.815900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.161200E-01
Normal-vs-AfricanAmerican
2.363000E-01
Normal-vs-Asian
7.008800E-01
Caucasian-vs-AfricanAmerican
3.617800E-01
Caucasian-vs-Asian
7.098800E-01
AfricanAmerican-vs-Asian
6.786000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.304600E-01
Normal-vs-Female
7.720400E-01
Male-vs-Female
6.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.123200E-01
Normal-vs-Age(41-60Yrs)
6.944800E-01
Normal-vs-Age(61-80Yrs)
7.398200E-01
Normal-vs-Age(81-100Yrs)
3.257000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.293000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.835600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.093600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.150600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.141600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.097600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.143800E-01
Normal-vs-Daily Drinker
9.681800E-01
Normal-vs-Weekly Drinker
4.024000E-01
Normal-vs-Occasional Drinker
3.811200E-01
Normal-vs-Social Drinker
8.268600E-01
Non Drinker-vs-Daily Drinker
7.474400E-01
Non Drinker-vs-Weekly Drinker
8.991700E-02
Non Drinker-vs-Occasional Drinker
2.710400E-01
Non Drinker-vs-Social Drinker
5.493600E-01
Daily Drinker-vs-Weekly Drinker
8.578100E-02
Daily Drinker-vs-Occasional Drinker
9.188100E-02
Daily Drinker-vs-Social Drinker
7.766200E-01
Weekly Drinker-vs-Occasional Drinker
4.020200E-01
Weekly Drinker-vs-Social Drinker
6.357700E-02
Occasional Drinker-vs-Social Drinker
5.339800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.612400E-01
Normal-vs-Grade 2
8.738400E-01
Normal-vs-Grade 3
8.638200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.420100E-02
Grade 1-vs-Grade 3
1.202960E-01
Grade 1-vs-Grade 4
7.612400E-01
Grade 2-vs-Grade 3
8.505800E-01
Grade 2-vs-Grade 4
8.738400E-01
Grade 3-vs-Grade 4
8.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.325600E-01
Normal-vs-NonDiabetic
7.408600E-01
Diabetic-vs-NonDiabetic
9.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.376400E-01
Normal-vs-NoPancreatitis
6.982600E-01
Pancreatitis-vs-NoPancreatitis
8.316400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.353000E-01
Normal-vs-N1
7.357200E-01
N0-vs-N1
3.565200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.152400E-01
Normal-vs-TP53-NonMutant
5.546600E-01
TP53-Mutant-vs-TP53-NonMutant
4.917800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
